| Primary information |
|---|
| sequence ID | Seq_1728 |
| Peptide sequence | EEAPSLRPAPPPISGGG |
| CancerPDF_ID | CancerPDF_ID849, CancerPDF_ID10233, |
| PMID | 19795908,21805675 |
| Protein Name | Fibrinogen beta chain,Fibrinogen beta chain |
| UniprotKB Entry Name | FIBB_HUMAN,FIBB_HUMAN |
| Fluid | Plasma,Urine |
| M/Z | 816.41,1631.8263 |
| Charge | 2,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,MALDI-TOF |
| Peptide Identification technique | MALDI-TOF/TOF,MALDI-TOF-MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
| Labelled/Label Free | Labelled,Label Free |
| FDR | less than 7%,1 |
| CancerPDF_ID | CancerPDF_ID849, CancerPDF_ID10233, |
| p-Value | NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,NA |
| Length | 17,17 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Muscle-invasive bladder cancer |
| Database | NCBI refseq Protein Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | "42 normal, 26 patients",751 bladder cancer and 127 control |
| Regulation | NA,Differentially expressed between cancer vs normal samples |
| Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |